Novel α2β1 integrin-targeted peptide probes for prostate cancer imaging

Molecular Imaging

Volumn 10, Issue 4, 2011, Pages 284-294

  Huang, Chiun Wei ^a   Li, Zibo ^a   Cai, Hancheng ^a   Shahinian, Tony ^a   Conti, Peter S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING AFFINITIES; EXPERIMENTAL EVIDENCE; EXPRESSION LEVELS; FLOW CYTOMETRY ANALYSIS; FLUORESCENT DYES; HUMAN PROSTATE; HUMAN PROSTATE CANCER; IMAGING PROBE; IMMUNOFLUORESCENCE STAINING; IMMUNOHISTOCHEMISTRY; IN-VITRO; IN-VIVO; INTEGRINS; OVER-EXPRESSION; PROSTATE CANCERS; PROSTATE-CANCER IMAGING; TUMOR CELLS; TUMOR PROGRESSIONS;

BINDING ENERGY; CELL CULTURE; FLOW CYTOMETRY; FLUORESCENCE; MEDICAL IMAGING; PEPTIDES; PROBES; TUMORS;

DISEASES;

ASPARTYL GLYCYL GLUTAMYL ALANINE; ASPARTYL-GLYCYL-GLUTAMYL-ALANINE; FLUORESCENT DYE; OLIGOPEPTIDE; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC IMAGING; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; INTEGRIN ALPHA2BETA1; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PROSTATIC NEOPLASMS;

EID: 79959769182     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00044     Document Type: Article

References (39)

1. SEER: The Surveillance, Epidemiology, and End Results Program: cancer of the prostate statistics 2009. Available at: http://seer.cancer.gov/statfacts/ html/prost.html (accessed December 1, 2009).
2. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
3. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-23.
4. Bubendorf L, Schöpfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000;31:578-83. (Pubitemid 30323983)
5. Hall CL, Dai J, van Golen KL, et al. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Res 2006;66:8648-54. (Pubitemid 44449180)
6. Tantivejkul K, Kalikin LM, Pienta KJ. Dynamic process of prostate cancer metastasis to bone. J Cell Biochem 2004;91:706-17.
7. Keller ET, Zhang J, Cooper CR, et al. Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 2001;20:333-49. (Pubitemid 34595275)
8. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003;20:203-13. (Pubitemid 36513225)
9. Graham KL, Zeng W, Takada Y, et al. Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol 2004;78:11786-97.
10. Graham KL, Halasz P, Tan Y, et al. Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol 2003;77:9969-78. (Pubitemid 37122078)
11. Grzesiak JJ, Bouvet M. The α2β1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 2006;94:1311-9.
12. Lochter A, Navre M, Werb Z, et al. Alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell 1999;10:271-82. (Pubitemid 29156472)
13. Yamaguchi K, Ura H, Yasoshima T, et al. Establishment and characterization of a human gastric carcinoma cell line that is highly metastatic to lymph nodes. J Exp Clin Cancer Res 2000;19: 113-20. (Pubitemid 30305529)
14. Fishman DA, Kearns A, Chilukuri K, et al. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen. Invasion Metastasis 1998;18:15-26. (Pubitemid 29184850)
15. Kirkland SC, Ying H. Alpha2beta1 integrin regulates lineage commitment in multipotent human colorectal cancer cells. J Biol Chem 2008;283:27612-9.
16. Böhle A, Jurczok A, Ardelt P, et al. Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J Urol 2002;167:357-63. (Pubitemid 34024585)
17. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-51. (Pubitemid 41713363)
18. Patrawala L, Calhoun-Davis T, Schneider- Broussard R, et al. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007;67:6796-805. (Pubitemid 47105527)
19. Haywood-Reid PL, Zipf DR, Springer WR. Quantification of integrin subunits on human prostatic cell lines-comparison of nontumorigenic and tumorigenic lines. Prostate 1997;31:1-8. (Pubitemid 27172035)
20. Bonaccorsi L, Carloni V, Muratori M, et al. Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology 2000;141: 3172-82. (Pubitemid 32269005)
21. Bureyko T, Hurdle H, Metcalfe JB, et al. Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro. Br J Nutr 2009;101:990-7. [Epub 2008 Aug 21]
22. Staatz WD, Fok KF, Zutter MM, et al. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem 1991;266:7363-7. (Pubitemid 21906374)
23. Luzak B, Golanski J, Rozalski M, et al. Inhibition of collageninduced platelet reactivity by DGEA peptide. Acta Biochim Pol 2003;50:1119-28. (Pubitemid 38608840)
24. Graham KL, Zeng W, Takada Y, et al. Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J Virol 2004;78:11786-97. (Pubitemid 39390765)
25. Hancock WS, Battersby JE. A new micro-test for the detection of incomplete coupling reactions in solid-phase peptide synthesis using 2,4,6-trinitro benzenesulphonic acid. Anal Biochem 1976; 71(1):260-4.
26. Castel S, Pagan R, Mitjans F, et al. RGD peptides and monoclonal antibodies, antagonists of |[apha]|v-integrin, enter the cells by independent endocytic pathways. Lab Invest 2001;81:1615-26. (Pubitemid 33144424)
27. Sancey L, Garanger E, Foillard S, et al. Clustering and internalization of integrin avb3 with a tetrameric RGD-synthetic peptide. Mol Ther 2009;17:837-43.
28. Li Z, Wu Z, Chen K, et al. 18F-Labeled BBN-RGD heterodimer for prostate cancer imaging. J Nucl Med 2008;49:453-61. (Pubitemid 351355212)
29. Liu Z, Li Z, Cao Q, et al. Small-animal PET of tumors with 64Culabeled RGD-bombesin heterodimer. J Nucl Med 2009;50:1168-77.
30. Baer M, Ntam C, Reese CT, et al. Internalization of near-infrared fluorescent dyes within isolated leukocyte populations. Int J Environ Res Public Health 2006;3:31-7. (Pubitemid 350002710)
31. Do M, Haefner T, Liatsikos E, et al. Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: oncologic and functional outcomes of 100 cases. Urology 2010;75:1348-52.
32. Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 2002;52:154-79. (Pubitemid 34546107)
33. Stephens RJ, Dearnaley DP, Cowan R, et al. The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397). BJU Int 2007;99:301-10. (Pubitemid 46110433)
34. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001;1(1):34-45. (Pubitemid 33741879)
35. Chuu CP, Hiipakka RA, Fukuchi J, et al. Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Res 2005;65:2082-4. (Pubitemid 40490112)
36. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 2003;19:173-206. (Pubitemid 37487347)
37. Volpes R, van den Oord JJ, Desmet VJ. Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology 1991;101(1):200-6.
38. Sheppard D, Yokosaki Y. Roles of airway epithelial integrins in health and disease. The Parker B. Francis Lectureship. Chest 1996; 109:29s-33s.
39. Clarke MR, Landreneau RJ, Finkelstein SD, et al. Extracellular matrix expression in metastasizing and nonmetastasizing adenocarcinomas of the lung. Hum Pathol 1997;28(1):54-9. (Pubitemid 27044482)